Parkinson's Disease
- PMID: 30704685
- DOI: 10.1016/j.mcna.2018.10.014
Parkinson's Disease
Abstract
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and there should be no features from the history or examination to suggest an alternative cause of parkinsonism. In addition to the motor manifestations of PD, there is a long list of nonmotor symptoms, several of which occur before motor signs and are considered "prodromal" PD. These are classified as neuropsychiatric, autonomic, sleep, and sensory. There are many medical options for the treatment of PD but levodopa remains the mainstay. Deep brain stimulation and other advanced therapies are also available.
Keywords: Dyskinesias; Levodopa; Parkinsonism; Parkinson’s disease; REM sleep behavioral disorder; Tremor.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Diagnosis and Treatment of Parkinson Disease: A Review.JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360. JAMA. 2020. PMID: 32044947 Review.
-
Tremor Is Highly Responsive to Levodopa in Advanced Parkinson's Disease.Mov Disord Clin Pract. 2025 Jan;12(1):76-81. doi: 10.1002/mdc3.14262. Epub 2024 Nov 9. Mov Disord Clin Pract. 2025. PMID: 39520315 Free PMC article.
-
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.Acta Neurochir (Wien). 2008 Jan;150(1):15-22; discussion 22. doi: 10.1007/s00701-007-1451-3. Epub 2008 Jan 10. Acta Neurochir (Wien). 2008. PMID: 18180867
-
Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.Mov Disord. 2014 Feb;29(2):207-13. doi: 10.1002/mds.25650. Epub 2013 Sep 16. Mov Disord. 2014. PMID: 24105646
-
Diagnosis and Management of Parkinson's Disease.Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16. Semin Neurol. 2017. PMID: 28511252 Review.
Cited by
-
Secondary Bioactive Metabolites from Foods of Plant Origin as Theravention Agents against Neurodegenerative Disorders.Foods. 2024 Jul 20;13(14):2289. doi: 10.3390/foods13142289. Foods. 2024. PMID: 39063373 Free PMC article. Review.
-
Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews.J Parkinsons Dis. 2021;11(3):919-935. doi: 10.3233/JPD-202521. J Parkinsons Dis. 2021. PMID: 33814465 Free PMC article. Review.
-
Cryptotanshinone ameliorates MPP+-induced oxidative stress and apoptosis of SH-SY5Y neuroblastoma cells: the role of STAT3 in Parkinson's disease.Metab Brain Dis. 2022 Jun;37(5):1477-1485. doi: 10.1007/s11011-022-00905-w. Epub 2022 Apr 9. Metab Brain Dis. 2022. PMID: 35396628
-
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.Int J Mol Sci. 2022 Apr 25;23(9):4718. doi: 10.3390/ijms23094718. Int J Mol Sci. 2022. PMID: 35563107 Free PMC article. Review.
-
Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP-1 and modulating gut microbiota.Bioeng Transl Med. 2022 Jun 18;8(5):e10351. doi: 10.1002/btm2.10351. eCollection 2023 Sep. Bioeng Transl Med. 2022. PMID: 37693045 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical